ID: ALA5202132

Max Phase: Preclinical

Molecular Formula: C19H17FN2O5S

Molecular Weight: 404.42

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(F)cc1N(C)C(=O)c1ccc(-c2ccc(OS(N)(=O)=O)cc2)o1

Standard InChI:  InChI=1S/C19H17FN2O5S/c1-12-3-6-14(20)11-16(12)22(2)19(23)18-10-9-17(26-18)13-4-7-15(8-5-13)27-28(21,24)25/h3-11H,1-2H3,(H2,21,24,25)

Standard InChI Key:  HSBFOIKRCUCYNZ-UHFFFAOYSA-N

Associated Targets(Human)

Steryl-sulfatase 1865 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 404.42Molecular Weight (Monoisotopic): 404.0842AlogP: 3.25#Rotatable Bonds: 5
Polar Surface Area: 102.84Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.71CX Basic pKa: CX LogP: 2.86CX LogD: 2.86
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.70Np Likeness Score: -1.43

References

1. Mohamed A, Salah M, Tahoun M, Hawner M, Abdelsamie AS, Frotscher M..  (2022)  Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.,  65  (17.0): [PMID:35993890] [10.1021/acs.jmedchem.2c00589]

Source